Safety and effectiveness of the booster dose of mRNA COVID-19 vaccines in people with multiple sclerosis: A monocentric experience
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and effectiveness of the booster dose of mRNA COVID-19 vaccines in people with multiple sclerosis: A monocentric experience
Authors
Keywords
-
Journal
Multiple Sclerosis and Related Disorders
Volume 72, Issue -, Pages 104582
Publisher
Elsevier BV
Online
2023-02-25
DOI
10.1016/j.msard.2023.104582
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The T cell immune response against SARS-CoV-2
- (2022) Paul Moss NATURE IMMUNOLOGY
- COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose
- (2022) Sapir Dreyer-Alster et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients
- (2022) Gisella Guerrera et al. Multiple Sclerosis Journal
- Persistence of Anti-SARS-CoV-2 Spike IgG Antibodies Following COVID-19 Vaccines
- (2022) Naif Khalaf Alharbi et al. Infection and Drug Resistance
- COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021
- (2021) Anat Achiron et al. Multiple Sclerosis Journal
- Multiple sclerosis: Is there a risk of worsening after yellow fever vaccination?
- (2021) Caroline Papeix et al. Multiple Sclerosis Journal
- Risk and outcomes of COVID‐19 in patients with multiple sclerosis
- (2021) Irene Moreno‐Torres et al. EUROPEAN JOURNAL OF NEUROLOGY
- mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis
- (2021) Massimiliano Di Filippo et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy
- (2021) Sokratis A. Apostolidis et al. NATURE MEDICINE
- Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies
- (2021) Maria Pia Sormani et al. EBioMedicine
- Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies
- (2021) Fioravante Capone et al. Neurotherapeutics
- Longitudinal humoral response after SARS-CoV-2 vaccination in ocrelizumab treated MS patients: To wait and repopulate?
- (2021) Z.L.E. van Kempen et al. Multiple Sclerosis and Related Disorders
- Risk of MS relapse after yellow fever vaccination
- (2020) Angela Huttner et al. Neurology-Neuroimmunology & Neuroinflammation
- Rituximab-Treated Patients Have a Poor Response to Influenza Vaccination
- (2012) Robert A. Eisenberg et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- Yellow Fever Vaccination and Increased Relapse Rate in Travelers With Multiple Sclerosis
- (2011) Mauricio F. Farez ARCHIVES OF NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started